55
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Long-term Ergotamine Derivative Therapy for Migraine Associated with Pachymeningitis and Sixth Cranial Nerve Palsy

, &
Pages 417-420 | Received 12 Jul 2018, Accepted 18 Sep 2018, Published online: 05 Oct 2018

References

  • Goyal M, Malik A, Mishra NK, Gaikwad SB. Idiopathic hypertrophic pachymeningitis: spectrum of the disease. Neuroradiology. 1997;39:619–623.
  • Zhou Z, Li Q, Zheng J. Hypertrophic cranial pachymeningitis induced by long-term administration of nonsteroidal antiinflammatory drugs. Ann Pharmacother. 2010;44(4):755–759. doi:10.1345/aph.1M455.
  • Ahmed M, Luggen M, Herman JH, et al. Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol. 2006;33:2344–2346.
  • Tfelt-Hansen P, Saxena P, Dahlöf C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000;123:9–18.
  • Allen M, Tosh G, Walters G, Muers M. Pleural and pericardial fibrosis after ergotamine therapy. Respir Med. 1994;88:67–69.
  • Bigal ME, Tepper SJ. Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003;7:55–62.
  • Silberstein S. Methysergide. Cephalalgia. 1998;18(7):421–435. doi:10.1111/j.1468-2982.1998.1807421.x.
  • Alberti C. Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology. Il Giornale di chirurgia. 2015;36:187.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.